Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bebo HealthXPAR:MLBBO 47 14-Day RSI is 33.59 as of Jul. 22, 2026. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,142 Retail - Cyclical companies, Bebo Health ranks better than 91.16% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-22), Bebo Health's 14-Day RSI is 33.59.
The industry rank for Bebo Health's 14-Day RSI or its related term are showing as below:
XPAR:MLBBO's 14-Day RSI is ranked better than 91.16% of 1142
companies
in the Retail - Cyclical industry
Industry Median: 49.28
vs XPAR:MLBBO: 33.59
Bebo Health (XPAR:MLBBO) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Bebo Health 14-Day RSI Related Terms
XPAR:MLBBO vs CASY, WSM, DKS: 14-Day RSI Comparison
For the Specialty Retail subindustry, Bebo Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health 14-Day RSI vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Bebo Health's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health (XPAR:MLBBO) has a 14-Day RSI of 33.59 as of Jul. 22, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Bebo Health and its competitors. According to the industry distribution chart, Bebo Health ranks #101 out of 1142 companies in the Retail - Cyclical industry, placing it in the top 8.8%.
Is Bebo Health's 14-Day RSI too high?
Bebo Health's current 14-Day RSI is 33.59. The Retail - Cyclical industry median 14-Day RSI is 49.28. Bebo Health's value of 33.59 is 31.8% below this industry median. Based on the distribution chart, Bebo Health ranks #101 out of 1142 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's 14-Day RSI compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #101 out of 1142 companies for 14-Day RSI. This places Bebo Health in the top 9% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.28. Bebo Health's value of 33.59 is 31.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Retail - Cyclical company?
The median 14-Day RSI among Retail - Cyclical companies is 49.28, based on 1,142 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current 14-Day RSI of 33.59 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median 14-Day RSI is 49.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current 14-Day RSI is 33.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current 14-Day RSI is 33.59 and 31.8% below the Retail - Cyclical industry median of 49.28. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current 14-Day RSI is 33.59 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
14-Day RSI: 33.59
GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
Industry Position: 31.8% below the Retail - Cyclical median (#101 of 1142)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 
